ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Rotavirus Vaccine Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-14F9825
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Rotavirus Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Human Rotavirus Vaccine Market Research Report 2025

Code: QYRE-Auto-14F9825
Report
August 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bharat Biotech
Merck
GlaxoSmithKline PLC

Human Rotavirus Vaccine Market Size

The global market for Human Rotavirus Vaccine was valued at US$ 201 million in the year 2024 and is projected to reach a revised size of US$ 251 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Human Rotavirus Vaccine Market

Human Rotavirus Vaccine Market

Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rotavirus Vaccine.
The Human Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Rotavirus Vaccine Market Report

Report Metric Details
Report Name Human Rotavirus Vaccine Market
Accounted market size in year US$ 201 million
Forecasted market size in 2031 US$ 251 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Rotarix
  • RotaTeq
  • Rotavac
  • Rotavin-M1
  • Lanzhou lamb
  • Others
Segment by Application
  • Hospitals & Clinics
  • Academic And Research
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bharat Biotech, Merck, GlaxoSmithKline
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Rotavirus Vaccine Market growing?

Ans: The Human Rotavirus Vaccine Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Human Rotavirus Vaccine Market size in 2031?

Ans: The Human Rotavirus Vaccine Market size in 2031 will be US$ 251 million.

Who are the main players in the Human Rotavirus Vaccine Market report?

Ans: The main players in the Human Rotavirus Vaccine Market are Bharat Biotech, Merck, GlaxoSmithKline

What are the Application segmentation covered in the Human Rotavirus Vaccine Market report?

Ans: The Applications covered in the Human Rotavirus Vaccine Market report are Hospitals & Clinics, Academic And Research, Others

What are the Type segmentation covered in the Human Rotavirus Vaccine Market report?

Ans: The Types covered in the Human Rotavirus Vaccine Market report are Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others

1 Human Rotavirus Vaccine Market Overview
1.1 Product Definition
1.2 Human Rotavirus Vaccine by Type
1.2.1 Global Human Rotavirus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Human Rotavirus Vaccine by Application
1.3.1 Global Human Rotavirus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals & Clinics
1.3.3 Academic And Research
1.3.4 Others
1.4 Global Human Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Rotavirus Vaccine Revenue 2020-2031
1.4.2 Global Human Rotavirus Vaccine Sales 2020-2031
1.4.3 Global Human Rotavirus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Rotavirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Rotavirus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rotavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rotavirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Human Rotavirus Vaccine, Date of Enter into This Industry
2.8 Global Human Rotavirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Human Rotavirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Rotavirus Vaccine Players Market Share by Revenue
2.8.3 Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Rotavirus Vaccine Market Scenario by Region
3.1 Global Human Rotavirus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Rotavirus Vaccine Sales by Region: 2020-2031
3.2.1 Global Human Rotavirus Vaccine Sales by Region: 2020-2025
3.2.2 Global Human Rotavirus Vaccine Sales by Region: 2026-2031
3.3 Global Human Rotavirus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Human Rotavirus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Human Rotavirus Vaccine Revenue by Region: 2026-2031
3.4 North America Human Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Human Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Rotavirus Vaccine Sales by Country (2020-2031)
3.4.3 North America Human Rotavirus Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Rotavirus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Human Rotavirus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Human Rotavirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Rotavirus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Rotavirus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Rotavirus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Human Rotavirus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Rotavirus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Rotavirus Vaccine Sales by Type (2020-2031)
4.1.1 Global Human Rotavirus Vaccine Sales by Type (2020-2025)
4.1.2 Global Human Rotavirus Vaccine Sales by Type (2026-2031)
4.1.3 Global Human Rotavirus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Human Rotavirus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Human Rotavirus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Human Rotavirus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Human Rotavirus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Human Rotavirus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Rotavirus Vaccine Sales by Application (2020-2031)
5.1.1 Global Human Rotavirus Vaccine Sales by Application (2020-2025)
5.1.2 Global Human Rotavirus Vaccine Sales by Application (2026-2031)
5.1.3 Global Human Rotavirus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Human Rotavirus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Human Rotavirus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Human Rotavirus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Human Rotavirus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Human Rotavirus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Company Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bharat Biotech Human Rotavirus Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Human Rotavirus Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rotavirus Vaccine Industry Chain Analysis
7.2 Human Rotavirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rotavirus Vaccine Production Mode & Process Analysis
7.4 Human Rotavirus Vaccine Sales and Marketing
7.4.1 Human Rotavirus Vaccine Sales Channels
7.4.2 Human Rotavirus Vaccine Distributors
7.5 Human Rotavirus Vaccine Customer Analysis
8 Human Rotavirus Vaccine Market Dynamics
8.1 Human Rotavirus Vaccine Industry Trends
8.2 Human Rotavirus Vaccine Market Drivers
8.3 Human Rotavirus Vaccine Market Challenges
8.4 Human Rotavirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bharat Biotech
Merck
GlaxoSmithKline PLC
List of Tables
 Table 1. Global Human Rotavirus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Rotavirus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Rotavirus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Rotavirus Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Rotavirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Rotavirus Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Rotavirus Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Human Rotavirus Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rotavirus Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Rotavirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Rotavirus Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Rotavirus Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Human Rotavirus Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Rotavirus Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Human Rotavirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Rotavirus Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Rotavirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Rotavirus Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Rotavirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Rotavirus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Rotavirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Rotavirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Rotavirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Rotavirus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Rotavirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Rotavirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Rotavirus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Rotavirus Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Rotavirus Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Rotavirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Rotavirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Rotavirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Rotavirus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Rotavirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Rotavirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Rotavirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Rotavirus Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Rotavirus Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Rotavirus Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Human Rotavirus Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Human Rotavirus Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Rotavirus Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Rotavirus Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Rotavirus Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Rotavirus Vaccine Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Human Rotavirus Vaccine Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Human Rotavirus Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Rotavirus Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Rotavirus Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Human Rotavirus Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Human Rotavirus Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Rotavirus Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Rotavirus Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Rotavirus Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Rotavirus Vaccine Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Human Rotavirus Vaccine Price (USD/Unit) by Application (2026-2031)
 Table 70. Bharat Biotech Company Information
 Table 71. Bharat Biotech Description and Business Overview
 Table 72. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bharat Biotech Human Rotavirus Vaccine Product
 Table 74. Bharat Biotech Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Human Rotavirus Vaccine Product
 Table 79. Merck Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Human Rotavirus Vaccine Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Human Rotavirus Vaccine Distributors List
 Table 88. Human Rotavirus Vaccine Customers List
 Table 89. Human Rotavirus Vaccine Market Trends
 Table 90. Human Rotavirus Vaccine Market Drivers
 Table 91. Human Rotavirus Vaccine Market Challenges
 Table 92. Human Rotavirus Vaccine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Rotavirus Vaccine
 Figure 2. Global Human Rotavirus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Rotavirus Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Rotarix Product Picture
 Figure 5. RotaTeq Product Picture
 Figure 6. Rotavac Product Picture
 Figure 7. Rotavin-M1 Product Picture
 Figure 8. Lanzhou lamb Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Human Rotavirus Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Human Rotavirus Vaccine Market Share by Application: 2024 & 2031
 Figure 12. Hospitals & Clinics
 Figure 13. Academic And Research
 Figure 14. Others
 Figure 15. Global Human Rotavirus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Human Rotavirus Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Human Rotavirus Vaccine Sales (2020-2031) & (K Units)
 Figure 18. Global Human Rotavirus Vaccine Average Price (USD/Unit) & (2020-2031)
 Figure 19. Human Rotavirus Vaccine Report Years Considered
 Figure 20. Human Rotavirus Vaccine Sales Share by Manufacturers in 2024
 Figure 21. Global Human Rotavirus Vaccine Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Human Rotavirus Vaccine Players: Market Share by Revenue in Human Rotavirus Vaccine in 2024
 Figure 23. Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Human Rotavirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Human Rotavirus Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. North America Human Rotavirus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Human Rotavirus Vaccine Sales Market Share by Country (2020-2031)
 Figure 30. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Region (2020-2031)
 Figure 38. China Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Human Rotavirus Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Human Rotavirus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Human Rotavirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Human Rotavirus Vaccine by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Human Rotavirus Vaccine by Type (2020-2031)
 Figure 60. Global Human Rotavirus Vaccine Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Human Rotavirus Vaccine by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Human Rotavirus Vaccine by Application (2020-2031)
 Figure 63. Global Human Rotavirus Vaccine Price (USD/Unit) by Application (2020-2031)
 Figure 64. Human Rotavirus Vaccine Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions